VISN 22 wide infectious molecular pathology cost-per-test BPA
Ended Awarded Last action
- Contract number
- 36C26222N1040
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $64,153
Award facts
- Contract value 100% obligated
- $64,152.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
- Legislative mandates
-
- Davis-Bacon Act FAR subpart 22.4
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$7,868 | |
| Supplemental Agreement for work within scope | -$227,979 | |
| Original award | $300,000 |
About this award
Roche Diagnostics Corporation received a Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network (VISN) 22 for infectious molecular pathology testing services on a cost-per-test basis, with a ceiling value of $64,152.99. The contract, issued September 27, 2022, with ultimate completion on September 26, 2023, represents a firm fixed-price delivery order under the larger VISN 22 BPA for immunohistochemistry and in-situ hybridization equipment and services valued at $3.1 million through September 2030. The award carries no set-aside designation and will be performed at the contractor's facility in Castleton, Indiana. This award reflects the Department of Veterans Affairs' continued reliance on Roche's diagnostic capabilities to support laboratory testing requirements across the veterans healthcare system.
As a leading in vitro diagnostics manufacturer, Roche Diagnostics Corporation supplies molecular diagnostic analyzers, reagents, and associated testing services to federal healthcare agencies including the Department of Veterans Affairs, Defense Health Agency, and Centers for Disease Control and Prevention. The company maintains an extensive portfolio of federal contracts spanning multiple VISNs and military medical centers, providing comprehensive laboratory testing solutions. This VISN 22 award is consistent with Roche's established presence within the VA healthcare system and demonstrates the agency's confidence in the contractor's ability to deliver specialized infectious disease molecular pathology testing to support clinical laboratory operations at VA medical facilities.
Quick answers
Who was awarded contract 36C26222N1040?
36C26222N1040 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 22 (Veterans Health Administration) on September 27, 2022.
How much is contract 36C26222N1040 worth?
The government has obligated $64,153 on 36C26222N1040.
Is contract 36C26222N1040 an order under another contract?
Yes. 36C26222N1040 is a BPA call under 36C26218A0021, a blanket purchase agreement.
Was contract 36C26222N1040 competed?
The extent of competition for 36C26222N1040 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award